Wiberg Cleveland posted an update 1 week, 1 day ago
Seen from results from Lab testing, the Food and Drug Administration has determined that Zantac® and various ranitidine based medications contain a nitrosamine issue called N–nitrosodimethylamine (NDMA) at low levels. NDMA is thought of as a probable human carcinogen – a substance which could cause cancer in humans. NDMA is a classified environmental contaminant and found in water supplies and foods, including meats, dairy products, and produce.
What is NDMA?
N–nitrosodimethylamine (NDMA) is classified as a probable human carcinogen that means that it’s more likely than not to cause cancer in humans. NDMA has been researched in animal populations and found to increase the creation of cancer in the animals. The studies have raised the chance of an association between NDMA and liver toxicity that may lead to the development of liver cancer and other connected conditions brought about from an NDMA–induced reaction to the liver.
The degree and duration of human NDMA exposure which can lead to the development of cancer is not exactly known. Also, the extent and duration of the NDMA contamination of Zantac® and various ranitidine medicines are not precisely known.
Issues Connected with Exposure to NDMA
NDMA has been researched in animal populations and found to increase the happening of cancer in the animals. Due to these studies, the US EPA classifies NDMA as a likely human carcinogen. The studies have increased the probability of an association between NDMA and liver toxicity which may lead to the creation of liver cancer and other related issues brought about by an NDMA injury to the liver. Others have suggested that NDMA might also be linked to other cancers such as:
Stomach Cancer, Liver Cancer, Pancreatic Cancer, Non–Hodgkin’s Lymphoma.
Have Other Ranitidine Products Been Recalled?
Yes. The U.S. Food and Drug Administration has alerted health care professionals and patients to three existing voluntary recalls of ranitidine.
Perrigo Company plc has voluntarily recalled over–the–counter (OTC) ranitidine tablets because of the potential of N–Nitrosodimethylamine (NDMA) in the medication.
Novitium Pharma LLC has voluntarily recalled all unexpired quantities and lots of ranitidine hydrochloride medication due to the possibility of NDMA in the medicine.
zantac injury , Inc. has voluntarily recalled all unexpired lots of prescription ranitidine syrup due to the presence of NDMA found in the drug.
Should I Cease Taking Zantac® or Other Ranitidine Medications?
As of October 28, 2019, the FDA advised patients and consumers taking Zantac® and other ranitidine medicines as follows:
“Patients taking prescription ranitidine who wish to stop should talk to their health care professional about other treatment options. Consumers taking OTC ranitidine, which is used to prevent and relieve heartburn associated with acid indigestion and sour stomach, may consider using other OTC products approved for their condition. FDA’s testing of samples of alternatives such as Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole), and Prilosec (omeprazole) show no NDMA in these medicines.”
Meneo Law Group is a leading consumer advocate for the recovery of damages because of to NDMA injury. Feel free to contact us at any time to discuss your injury and potential for recovery.